Cargando…

Organ-specific and tumor-size-dependent responses to sunitinib in clear cell renal cell carcinoma

BACKGROUND: Tyrosine kinase inhibitors (TKIs) have been used as standard therapy for patients with advanced renal cell carcinoma (RCC). However, information on factors predicting response to treatment with TKIs is lacking. This study aimed to assess the association between initial tumor size, involv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsuchiya, Norihiko, Yuasa, Takeshi, Maita, Shinya, Narita, Shintaro, Inoue, Takamitsu, Numakura, Kazuyuki, Saito, Mitsuru, Satoh, Shigeru, Yonese, Junji, Habuchi, Tomonori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975282/ https://www.ncbi.nlm.nih.gov/pubmed/24612599 http://dx.doi.org/10.1186/1471-2490-14-26

Ejemplares similares

Clinical implications of pharmacokinetics of sunitinib malate and N-desethyl-sunitinib plasma concentrations for treatment outcome in metastatic renal cell carcinoma patients
por: Numakura, Kazuyuki, et al.
Publicado: (2018)

Short-term clinicopathological outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade, followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in Japanese patients with high-risk localized prostate cancer
por: Narita, Shintaro, et al.
Publicado: (2012)

Successful mammalian target of rapamycin inhibitor maintenance therapy following induction chemotherapy with gemcitabine and doxorubicin for metastatic sarcomatoid renal cell carcinoma
por: NUMAKURA, KAZUYUKI, et al.
Publicado: (2014)

Characterization of prostate cancer detected at repeat biopsy
por: Yuasa, Takeshi, et al.
Publicado: (2008)

The impact of obesity and adiponectin signaling in patients with renal cell carcinoma: A potential mechanism for the “obesity paradox”
por: Ito, Ryuichi, et al.
Publicado: (2017)

Prognostic value of plasminogen activator inhibitor‐1 in biomarker exploration using multiplex immunoassay in patients with metastatic renal cell carcinoma treated with axitinib
por: Honma, Naoko, et al.
Publicado: (2020)

Successful Local Control of Recurrent Penile Cancer Treated with a Combination of Systemic Chemotherapy, Irradiation, and Mohs’ Paste: A Case Report
por: Komine, Naoki, et al.
Publicado: (2014)

Host-related Risk Factors for Adherent Perinephric Fat in Healthy Individuals Undergoing Laparoscopic Living-donor Nephrectomy
por: Narita, Shintaro, et al.
Publicado: (2017)

Robot-assisted laparoscopic pyeloplasty for ureteropelvic junction obstruction with duplex system
por: Numakura, Kazuyuki, et al.
Publicado: (2020)

Insulin-like growth factor-1 genotypes and haplotypes influence the survival of prostate cancer patients with bone metastasis at initial diagnosis
por: Tsuchiya, Norihiko, et al.
Publicado: (2013)

Secondary bladder amyloidosis with familial Mediterranean fever in a living donor kidney transplant recipient: a case report
por: Imamura, Sentaro, et al.
Publicado: (2016)

Fatty acid binding protein 4 enhances prostate cancer progression by upregulating matrix metalloproteinases and stromal cell cytokine production
por: Huang, Mingguo, et al.
Publicado: (2017)

Overweight Patients Less Improved Kidney Function After Laparoscopic Surgery for Adrenocortical Adenoma With Excess Cortisol Secretion
por: Numakura, Kazuyuki, et al.
Publicado: (2019)

A genetic polymorphism of the osteoprotegerin gene is associated with an increased risk of advanced prostate cancer
por: Narita, Naofumi, et al.
Publicado: (2008)

Characterization of Clinical and Genetic Risk Factors Associated with Dyslipidemia after Kidney Transplantation
por: Numakura, Kazuyuki, et al.
Publicado: (2015)

Impact of early changes in serum biomarkers following androgen deprivation therapy on clinical outcomes in metastatic hormone-sensitive prostate cancer
por: Sato, Hiromi, et al.
Publicado: (2018)

Incidence, Etiology, Prevention and Management of Ureteroenteric Strictures after Robot-Assisted Radical Cystectomy: A Review of Published Evidence and Personal Experience
por: Narita, Shintaro, et al.
Publicado: (2021)

Post-transplant lymphoproliferative disorder involving the ovary as an initial manifestation: a case report
por: Inoue, Takamitsu, et al.
Publicado: (2010)

Impact of nuclear YAP1 expression in residual cancer after neoadjuvant chemohormonal therapy with docetaxel for high-risk localized prostate cancer
por: Matsuda, Yoshinori, et al.
Publicado: (2020)

Capability of Utilizing CYP3A5 Polymorphisms to Predict Therapeutic Dosage of Tacrolimus at Early Stage Post-Renal Transplantation
por: Niioka, Takenori, et al.
Publicado: (2015)

Factors influencing warm ischemia time in robot-assisted partial nephrectomy change depending on the surgeon’s experience
por: Numakura, Kazuyuki, et al.
Publicado: (2022)

Prediction of Tacrolimus Exposure by CYP3A5 Genotype and Exposure of Co-Administered Everolimus in Japanese Renal Transplant Recipients
por: Kagaya, Hideaki, et al.
Publicado: (2018)

Macrophage inhibitory cytokine‐1 induced by a high‐fat diet promotes prostate cancer progression by stimulating tumor‐promoting cytokine production from tumor stromal cells
por: Huang, Mingguo, et al.
Publicado: (2021)

Effects of NR1I2 and ABCB1 Genetic Polymorphisms on Everolimus Pharmacokinetics in Japanese Renal Transplant Patients
por: Yagishita, Hironobu, et al.
Publicado: (2022)

Altering phosphoinositides in high‐fat diet‐associated prostate tumor xenograft growth
por: Huang, Mingguo, et al.
Publicado: (2021)

Outcomes of axitinib versus sunitinib as first‐line therapy to patients with metastatic renal cell carcinoma in the immune‐oncology era
por: Numakura, Kazuyuki, et al.
Publicado: (2021)

First-line axitinib therapy is less effective in metastatic renal cell carcinoma with spindle histology
por: Numakura, Kazuyuki, et al.
Publicado: (2020)

Early onset recall pneumonitis during targeted therapy with sunitinib
por: Yuasa, Takeshi, et al.
Publicado: (2013)

Severe Immune-Related Adverse Events in Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma Are Associated with PDCD1 Polymorphism
por: Kobayashi, Mizuki, et al.
Publicado: (2022)

Complete remission of brain metastases in renal cell carcinoma treated with axitinib after failure with nivolumab and ipilimumab treatment
por: Takayama, Koichiro, et al.
Publicado: (2022)

Specific Gut Microbial Environment in Lard Diet-Induced Prostate Cancer Development and Progression
por: Sato, Hiromi, et al.
Publicado: (2022)

Cytotoxic T Lymphocytes Regenerated from iPS Cells Have Therapeutic Efficacy in a Patient-Derived Xenograft Solid Tumor Model
por: Kashima, Soki, et al.
Publicado: (2020)

BRCA2 Frameshift Mutation in de novo Small-Cell Neuroendocrine Carcinoma of the Prostate: A Case Report
por: Okubo, Keisuke, et al.
Publicado: (2023)

Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab
por: Takahashi, Shuhei, et al.
Publicado: (2022)

Research Evidence on High-Fat Diet-Induced Prostate Cancer Development and Progression
por: Narita, Shintaro, et al.
Publicado: (2019)

Diet-induced alteration of fatty acid synthase in prostate cancer progression
por: Huang, M, et al.
Publicado: (2016)

Primary resistance to nivolumab plus ipilimumab therapy in patients with metastatic renal cell carcinoma
por: Numakura, Kazuyuki, et al.
Publicado: (2023)

Relationship of B7-H3 expression in tumor cells and tumor vasculature with FOXP3+ regulatory T cells in renal cell carcinoma
por: Inamura, Kentaro, et al.
Publicado: (2019)

Cancer Antigen 15-3 Serum Level as a Biomarker for Advanced Micropapillary Urothelial Carcinoma of the Bladder: A Case Report
por: Takayama, Koichiro, et al.
Publicado: (2021)

Cellular and physical microenvironments regulate the aggressiveness and sunitinib chemosensitivity of clear cell renal cell carcinoma
por: Nagase, Kei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j03uj0kfo94rjbom10f3edimjl